BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587-591. [PMID: 10706547 DOI: 10.1002/hep.510310307] [Cited by in Crossref: 439] [Cited by in F6Publishing: 335] [Article Influence: 20.9] [Reference Citation Analysis]
Number Citing Articles
1 Bleck JS, Terkamp C, Manns M, Gebel M. [Ultrasound of acute abdomen]. Internist (Berl) 2003;44:542-6, 548-52, 554-6. [PMID: 12966784 DOI: 10.1007/s00108-003-0913-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Salmela B, Nordin A, Vuoristo M, Mäkisalo H, Numminen K, Lassila R. Budd–Chiari syndrome in a young female with factor V Leiden mutation: Successful treatment with lepirudin, a direct thrombin inhibitor. Thrombosis Research 2008;121:769-72. [DOI: 10.1016/j.thromres.2007.08.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kapoor S, Pal S, Sahni P, Chattopadhyay TK. Thromboelastographic evaluation of coagulation in patients with extrahepatic portal vein thrombosis and non-cirrhotic portal fibrosis: a pilot study. J Gastroenterol Hepatol. 2009;24:992-997. [PMID: 19220674 DOI: 10.1111/j.1440-1746.2008.05761.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
4 Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP. Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis: Similarities and Differences. Arterioscler Thromb Vasc Biol 2011;31:485-93. [DOI: 10.1161/atvbaha.110.213371] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
5 Landolfi R, Cipriani MC, Novarese L. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: Pathogenetic mechanisms and prevention. Best Practice & Research Clinical Haematology 2006;19:617-33. [DOI: 10.1016/j.beha.2005.07.011] [Cited by in Crossref: 61] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
6 Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115-9. [PMID: 16610067 DOI: 10.3748/wjg.v12.i13.2115] [Cited by in CrossRef: 254] [Cited by in F6Publishing: 183] [Article Influence: 16.9] [Reference Citation Analysis]
7 Chait Y, Condat B, Cazals-Hatem D, Rufat P, Atmani S, Chaoui D, Guilmin F, Kiladjian JJ, Plessier A, Denninger MH. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 2005;129:553-560. [PMID: 15877740 DOI: 10.1111/j.1365-2141.2005.05490.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
8 Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691-697. [PMID: 15831918 DOI: 10.1136/gut.2004.042796]] [Reference Citation Analysis]
9 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
10 Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921-4928. [PMID: 23043069 DOI: 10.1182/blood-2011-09-376517] [Cited by in Crossref: 194] [Cited by in F6Publishing: 128] [Article Influence: 21.6] [Reference Citation Analysis]
11 Verna EC, Larghi A, Faddoul SG, Stein JA, Worman HJ. Portal Vein Thrombosis Associated with Fusobacterium Nucleatum Septicemia in a Patient with Ulcerative Colitis: . Journal of Clinical Gastroenterology 2004;38:611-2. [DOI: 10.1097/00004836-200408000-00014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
12 Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Ames PR, Iannaccone L, Grandone E, Romano L, Balzano A. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:2464-2470. [PMID: 17958760 DOI: 10.1111/j.1572-0241.2007.01477.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 129] [Article Influence: 13.8] [Reference Citation Analysis]
13 Rodríguez-Leal GA, Morán S, Corona-Cedillo R, Brom-Valladares R. Portal vein thrombosis with protein C-S deficiency in a non-cirrhotic patient. World J Hepatol 2014;6:532-7. [PMID: 25068006 DOI: 10.4254/wjh.v6.i7.532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
14 Cai XY, Zhou W, Hong DF, Cai XJ. A latent form of essential thrombocythemia presenting as portal cavernoma. World J Gastroenterol 2009;15:5368-70. [PMID: 19908349 DOI: 10.3748/wjg.15.5368] [Cited by in CrossRef: 5] [Article Influence: 0.5] [Reference Citation Analysis]
15 Murray KF, Carithers RL Jr;  AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005;41:1407-1432. [PMID: 15880505 DOI: 10.1002/hep.20704] [Cited by in Crossref: 519] [Cited by in F6Publishing: 374] [Article Influence: 32.4] [Reference Citation Analysis]
16 Khan F, Mehrzad H, Tripathi D. Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. J Transl Int Med. 2018;6:97-104. [PMID: 30425945 DOI: 10.2478/jtim-2018-0022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. [PMID: 17697371 DOI: 10.1186/1471-230x-7-34] [Cited by in Crossref: 108] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
18 Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, Eldorry A. Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study. World J Gastroenterol. 2011;17:4704-4710. [PMID: 22180713 DOI: 10.3748/wjg.v17.i42.4704] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
19 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16:143-155. [PMID: 20066733 DOI: 10.3748/wjg.v16.i2.143] [Cited by in CrossRef: 143] [Cited by in F6Publishing: 92] [Article Influence: 13.0] [Reference Citation Analysis]
20 Clark PJ, Slaughter RE, Radford DJ. Systemic thrombolysis for acute, severe Budd-Chiari syndrome. J Thromb Thrombolysis 2012;34:410-5. [DOI: 10.1007/s11239-012-0760-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
21 Brandt LJ. Thrombophilia and colon ischemia: Aura popularis? Gastroenterology 2001;121:724-6. [PMID: 11522756 DOI: 10.1053/gast.2001.27806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
22 P’ng S, Carnley B, Baker R, Kontorinis N, Cheng W. Undiagnosed Myeloproliferative Disease in Cases of Intra-Abdominal Thrombosis: The Utility of the JAK2 617F Mutation. Clinical Gastroenterology and Hepatology 2008;6:472-5. [DOI: 10.1016/j.cgh.2007.12.046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
23 Gangat N, Wolanskyj AP, Tefferi A. Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications. Eur J Haematol 2006;77:327-33. [PMID: 16856928 DOI: 10.1111/j.1600-0609.2006.00715.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
24 Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS. Redefining Budd-Chiari syndrome: A systematic review. World J Hepatol. 2016;8:691-702. [PMID: 27326316 DOI: 10.4254/wjh.v8.i16.691] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
25 De Stefano V, Martinelli I. Abdominal thromboses of splanchnic, renal and ovarian veins. Best Pract Res Clin Haematol 2012;25:253-64. [PMID: 22959542 DOI: 10.1016/j.beha.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
26 Elefsiniotis IS, Diamantis ID, Dourakis SP, Kafiri G, Pantazis K, Mavrogiannis C. Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis: . European Journal of Gastroenterology & Hepatology 2003;15:721-6. [DOI: 10.1097/01.meg.0000059140.68845.74] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
27 Imai H, Egawa H, Kajiwara M, Nakajima A, Ogura Y, Hatano E, Ueda M, Kawaguchi Y, Kaido T, Takada Y, Uemoto S. Resolution of Preoperative Portal Vein Thrombosis After Administration of Antithrombin III in Living Donor Liver Transplantation: Case Report. Transplantation Proceedings 2009;41:3931-3. [DOI: 10.1016/j.transproceed.2008.10.104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Pinto RB, Silveira TR, Bandinelli E, Röhsig L. Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. J Pediatr Surg 2004;39:1356-61. [PMID: 15359390 DOI: 10.1016/j.jpedsurg.2004.05.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
29 Galli L, Gerdes VE, Guasti L, Squizzato A. Thrombosis Associated with Viral Hepatitis. J Clin Transl Hepatol. 2014;2:234-239. [PMID: 26357629 DOI: 10.14218/jcth.2014.00031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
30 Qi X, De Stefano V, Wang J, Bai M, Yang Z, Han G, Fan D. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol. 2013;28:432-442. [PMID: 23216127 DOI: 10.1111/jgh.12085] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
31 Al-Holou S, Mathur AK, Ranney D, Kubus J, Englesbe MJ. Survival among children with portal vein thrombosis and end-stage liver disease. Pediatr Transplant 2010;14:132-7. [PMID: 19413719 DOI: 10.1111/j.1399-3046.2009.01175.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
32 Soyuncu S, Cete Y, Nokay AE. Portal vein thrombosis related to Cassia angustifolia. Clin Toxicol (Phila). 2008;46:774-777. [PMID: 19238740 DOI: 10.1080/15563650701682097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
33 Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2005;128:275-290. [PMID: 15667529 DOI: 10.1111/j.1365-2141.2004.05277.x] [Cited by in Crossref: 309] [Cited by in F6Publishing: 201] [Article Influence: 19.3] [Reference Citation Analysis]
34 Colovic RB, Grubor NM, Colic MU, Colovic NR, Atkinson HD. Portal cavernoma caused by a calcified hydatid cyst of the liver (case report). Eur J Gastroenterol Hepatol 2008;20:237-9. [PMID: 18301307 DOI: 10.1097/MEG.0b013e3282eeb4b1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol 2008;14:2858-62. [PMID: 18473410 DOI: 10.3748/wjg.14.2858] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
36 Draoua M, Titze N, Gupta A, Fernandez HT, Ramsay M, Saracino G, Mckenna G, Testa G, Klintmalm GB, Kim PTW. Significance of measured intraoperative portal vein flows after thrombendvenectomy in deceased donor liver transplantations with portal vein thrombosis. Liver Transpl 2017;23:1032-9. [DOI: 10.1002/lt.24779] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
37 DeLeve LD. Vascular liver diseases. Curr Gastroenterol Rep. 2003;5:63-70. [PMID: 12530950 DOI: 10.1007/s11894-003-0011-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
38 Janssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, Chamuleau RA, van Hattum J, Vleggaar FP, Hansen BE. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut. 2001;49:720-724. [PMID: 11600478 DOI: 10.1136/gut.49.5.720] [Cited by in Crossref: 199] [Cited by in F6Publishing: 156] [Article Influence: 10.0] [Reference Citation Analysis]
39 Plessier A. Syndrome de Budd-Chiari. Gastroentérologie Clinique et Biologique 2006;30:1162-9. [DOI: 10.1016/s0399-8320(06)73495-9] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
40 Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, Niu J, Wu K, Fan D. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013;28:148-52. [PMID: 23020629 DOI: 10.1111/j.1440-1746.2012.07282.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
41 Tiryaki TO, Yönal Hindilerden İ, Yegen G, Nalçacı M. Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis. Turk J Haematol 2020;37:130-1. [PMID: 32126743 DOI: 10.4274/tjh.galenos.2020.2019.0186] [Reference Citation Analysis]
42 Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denié C, Chagneau-Derrode C, Charpignon C, Lédinghen Vd, Grenouillet-Delacre M, Habersetzer F, Nousbaum JB, Denninger MH, Valla DC, Plessier A. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol. 2009;104:1140-1146. [PMID: 19337247 DOI: 10.1038/ajg.2009.63] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ayala R, Grande S, Bustelos R, Ribera C, García-Sesma A, Jimenez C, Moreno E, Martínez-López J. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol 2012;12:114. [PMID: 22909075 DOI: 10.1186/1471-230X-12-114] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
44 Seijo-ríos S, García-pagán JC. Trombosis portal. Gastroenterología y Hepatología 2010;33:179-90. [DOI: 10.1016/j.gastrohep.2009.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
45 Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44:1308-1316. [PMID: 17058215 DOI: 10.1002/hep.21354] [Cited by in Crossref: 188] [Cited by in F6Publishing: 119] [Article Influence: 12.5] [Reference Citation Analysis]
46 Amarapurkar P, Bhatt N, Patel N, Amarapurkar D. Primary extrahepatic portal vein obstruction in adults: A single center experience. Indian J Gastroenterol 2014;33:19-22. [DOI: 10.1007/s12664-013-0368-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
47 Khanna R, Sarin SK. Noncirrhotic Portal Hypertension: Current and Emerging Perspectives. Clin Liver Dis. 2019;23:781-807. [PMID: 31563222 DOI: 10.1016/j.cld.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
48 Bureau C, Laurent J, Robic MA, Christol C, Guillaume M, Ruidavets JB, Ferrieres J, Péron JM, Vinel JP. Central obesity is associated with non-cirrhotic portal vein thrombosis. Journal of Hepatology 2016;64:427-32. [DOI: 10.1016/j.jhep.2015.08.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
49 Amitrano L, Guardascione MA, Brancaccio V, Iannaccone L, Ames PR, Balzano A. Portal and mesenteric venous thrombosis in cirrhotic patients. Gastroenterology 2002;123:1409-10. [DOI: 10.1053/gast.2002.36391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
50 Colaizzo D, Tiscia GL, Bafunno V, Amitrano L, Vergura P, Lupone MR, Grandone E, Guardascione MA, Margaglione M. Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis. Thrombosis Research 2011;128:233-6. [DOI: 10.1016/j.thromres.2011.03.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
51 Van Wettere M, Bruno O, Rautou PE, Vilgrain V, Ronot M. Diagnosis of Budd-Chiari syndrome. Abdom Radiol (NY) 2018;43:1896-907. [PMID: 29285598 DOI: 10.1007/s00261-017-1447-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
52 Rajesh S, Mukund A, Arora A. Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract 2015;2015:101029. [PMID: 26600801 DOI: 10.1155/2015/101029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
53 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Clinics in Liver Disease 2009;13:127-44. [DOI: 10.1016/j.cld.2008.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
54 Swallow G, Pavord S. Portal vein thrombosis - experience in a single centre. Br J Haematol 2012;159:482-4. [DOI: 10.1111/bjh.12037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
55 Waits SA, Wojcik BM, Cai S, Mathur AK, Englesbe MJ. Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States. Liver Transpl 2011;17:1066-72. [PMID: 21744467 DOI: 10.1002/lt.22371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
56 Ravichandran P, Croome KP, Kovacs MJ, Lazo-Langner A, Hernandez-Alejandro R. Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough? Can J Gastroenterol Hepatol 2014;28:207-11. [PMID: 24729995 DOI: 10.1155/2014/353672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 Abdelrazeq AS, Dwaik MA, Aldoori MI, Lund JN, Leveson SH. Laparoscopy-Associated Portal Vein Thrombosis: Description of an Evolving Clinical Syndrome. Journal of Laparoendoscopic & Advanced Surgical Techniques 2006;16:9-14. [DOI: 10.1089/lap.2006.16.9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
58 Espinosa G, Font J, García-Pagan JC, Tàssies D, Reverter JC, Gaig C, Cervantes F, Cervera R, Bosch J, Ingelmo M. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore). 2001;80:345-354. [PMID: 11704712 DOI: 10.1097/00005792-200111000-00001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
59 Harrison CN. Platelets and Thrombosis in Myeloproliferative Diseases. Hematology 2005;2005:409-15. [DOI: 10.1182/asheducation-2005.1.409] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
60 McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:1009-1031. [PMID: 11139352 DOI: 10.1053/bega.2000.0144] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 4.0] [Reference Citation Analysis]
61 Wu X, Ding W, Cao J, Han J, Li J. Modified transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome. Int J Clin Pract. 2010;64:460-464. [PMID: 18435742 DOI: 10.1111/j.1742-1241.2008.01765.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
62 Cazals-Hatem D, Vilgrain V, Genin P, Denninger MH, Durand F, Belghiti J, Valla D, Degott C. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology. 2003;37:510-519. [PMID: 12601347 DOI: 10.1053/jhep.2003.50076] [Cited by in Crossref: 149] [Cited by in F6Publishing: 84] [Article Influence: 8.3] [Reference Citation Analysis]
63 De Stefano V, Rossi E, Za T, Ciminello A, Betti S, Luzzi C, Leone G, Chiusolo P. JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis. Am J Hematol 2011;86:526-8. [DOI: 10.1002/ajh.22024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
64 Zhou J, Mao W, Shen L, Huang H. Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis. Medicine (Baltimore) 2019;98:e18527. [PMID: 31876748 DOI: 10.1097/MD.0000000000018527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
65 De Stefano V, Za T, Ciminello A, Betti S, Rossi E. Causes of adult splanchnic vein thrombosis in the mediterranean area. Mediterr J Hematol Infect Dis. 2011;3:e2011063. [PMID: 22220260 DOI: 10.4084/mjhid.2011.063] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
66 Valla D. The diagnosis and management of the Budd-Chiari syndrome: Consensus and controversies. Hepatology 2003;38:793-803. [DOI: 10.1002/hep.1840380404] [Cited by in Crossref: 142] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
67 Gravholt CH, Mortensen KH, Andersen NH, Ibsen L, Ingerslev J, Hjerrild BE. Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome: Coagulation in Turner syndrome. Clinical Endocrinology 2012;76:649-56. [DOI: 10.1111/j.1365-2265.2011.04190.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
68 Ayala R, Martínez-López J, Cedena T, Bustelos R, Jimenez C, Moreno E, Ribera C. Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients. BMC Gastroenterol 2011;11:130. [PMID: 22123067 DOI: 10.1186/1471-230X-11-130] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
69 Bertoni M, Squizzato A, Foretic M, Zanieri S, Di Natale ME. Cytomegalovirus-associated splanchnic vein thrombosis in immunocompetent patients: A systematic review. Thrombosis Research 2018;168:104-13. [DOI: 10.1016/j.thromres.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
70 Orr DW, Harrison PM, Devlin J, Karani JB, Kane PA, Heaton ND, O'Grady JG, Heneghan MA. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol 2007;5:80-6. [PMID: 17142105 DOI: 10.1016/j.cgh.2006.09.030] [Cited by in Crossref: 65] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
71 Pietrobattista A, Luciani M, Abraldes JG, Candusso M, Pancotti S, Soldati M, Monti L, Torre G, Nobili V. Extrahepatic portal vein thrombosis in children and adolescents: Influence of genetic thrombophilic disorders. World J Gastroenterol 2010;16:6123-7. [PMID: 21182228 DOI: 10.3748/wjg.v16.i48.6123] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
72 Colaizzo D, Amitrano L, Guardascione MA, Tiscia GL, D'Andrea G, Longo VA, Grandone E, Margaglione M. Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation. Thromb Res 2013;132:e99-e104. [PMID: 23916380 DOI: 10.1016/j.thromres.2013.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
73 Shah TU, Semelka RC, Voultsinos V, Elias J Jr, Altun E, Pamuklar E, Firat Z, Gerber DA, Fair J, Russo MW. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl. 2006;12:1682-1688. [PMID: 16952167 DOI: 10.1002/lt.20873] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
74 Rai P, Kumar P, Mishra S, Aggarwal R. Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction. Indian J Gastroenterol 2016;35:366-71. [PMID: 27633031 DOI: 10.1007/s12664-016-0691-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
75 Janssen HLA, Leebeek FWG. JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis? Hepatology 2006;44:1391-3. [DOI: 10.1002/hep.21489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
76 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
77 Koshy A, Jeyakumari M. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Ann Hematol. 2006;85:126-128. [PMID: 16283309 DOI: 10.1007/s00277-005-0020-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
78 Tait C, Baglin T, Watson H, Laffan M, Makris M, Perry D, Keeling D; British Committee for Standards in Haematology. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol 2012;159:28-38. [DOI: 10.1111/j.1365-2141.2012.09249.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 48] [Article Influence: 9.1] [Reference Citation Analysis]
79 El-Karaksy HM, El-Koofy N, Mohsen N, Helmy H, Nabil N, El-Shabrawi M. Extrahepatic portal vein obstruction in Egyptian children. J Pediatr Gastroenterol Nutr 2015;60:105-9. [PMID: 25546337 DOI: 10.1097/MPG.0000000000000548] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
80 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 6.2] [Reference Citation Analysis]
81 Primignani M, Martinelli I, Bucciarelli P, Battaglioli T, Reati R, Fabris F, Dell'era A, Pappalardo E, Mannucci PM. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology. 2005;41:603-608. [PMID: 15726653 DOI: 10.1002/hep.20591] [Cited by in Crossref: 139] [Cited by in F6Publishing: 107] [Article Influence: 8.7] [Reference Citation Analysis]
82 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 291] [Cited by in F6Publishing: 172] [Article Influence: 48.5] [Reference Citation Analysis]
83 Socha P, Ryzko J, Janczyk W, Dzik E, Iwanczak B, Krzesiek E. Hepatic vein thrombosis as a complication of ulcerative colitis in a 12-year-old patient. Dig Dis Sci 2007;52:1293-8. [PMID: 17372822 DOI: 10.1007/s10620-006-9503-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
84 Abdel-Razik A, Mousa N, Shabana W, Yassen AH, Abdelsalam M, Wahba MM, Helmy EM, Tawfik AM, Zalata K, Hasan AS, Elhelaly R, Elzehery R, Fathy AA, El-Wakeel N, Eldars W. De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study. Front Med (Lausanne) 2021;8:650818. [PMID: 33996858 DOI: 10.3389/fmed.2021.650818] [Reference Citation Analysis]
85 Glatard AS, Hillaire S, d'Assignies G, Cazals-Hatem D, Plessier A, Valla DC, Vilgrain V. Obliterative portal venopathy: findings at CT imaging. Radiology. 2012;263:741-750. [PMID: 22474672 DOI: 10.1148/radiol.12111785] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
86 Oruc N, Tokat Y, Killi R, Tombuloglu M, Ilter T. Budd–Chiari Syndrome in an Afibrinogenemic Patient: A Paradoxical Complication. Dig Dis Sci 2006;51:378-80. [DOI: 10.1007/s10620-006-3141-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
87 De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern. Emerg Med. 2010;5:487-494. [PMID: 20532730 DOI: 10.1007/s11739-010-0413-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 7.2] [Reference Citation Analysis]
88 Talens S, Hoekstra J, Dirkx SP, Murad SD, Trebicka J, Elias E, Primignani M, García-pagán J, Valla DC, Janssen HL, Leebeek FW, Rijken DC. Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd–Chiari syndrome. Journal of Hepatology 2011;54:908-14. [DOI: 10.1016/j.jhep.2010.08.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
89 Seyahi E, Caglar E, Ugurlu S, Kantarci F, Hamuryudan V, Sonsuz A, Melikoglu M, Yurdakul S, Yazici H. An outcome survey of 43 patients with Budd–Chiari syndrome due to Behçet’s syndrome followed up at a single, dedicated center. Seminars in Arthritis and Rheumatism 2015;44:602-9. [DOI: 10.1016/j.semarthrit.2014.10.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
90 Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther. 2005;21:1-9. [PMID: 15644039 DOI: 10.1111/j.1365-2036.2004.02301.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 6.3] [Reference Citation Analysis]
91 Valla D. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19:S204-11. [DOI: 10.1111/j.1440-1746.2004.03642.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
92 Khan F, Armstrong MJ, Mehrzad H, Chen F, Neil D, Brown R, Cain O, Tripathi D. Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome. Aliment Pharmacol Ther. 2019;49:840-863. [PMID: 30828850 DOI: 10.1111/apt.15149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
93 Belkahla N, Maamouri N, Ouerghi H, Cheikh I, Hamida SB, Bouzid H, Ammar A. Thrombose portocave extensive révélant un syndrome primaire des anticorps antiphospholipides : à propos d’un cas. La Revue de Médecine Interne 2008;29:504-7. [DOI: 10.1016/j.revmed.2008.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Rajani R, Björnsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O, Melin T, Sangfelt P, Wallerstedt S, Almer S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010;32:1154-1162. [PMID: 21039677 DOI: 10.1111/j.1365-2036.2010.04454.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
95 Sabol TP, Molina M, Wu GY. Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol 2015;3:189-94. [PMID: 26623265 DOI: 10.14218/JCTH.2015.00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Spaander VMCW, Van Buuren HR, Janssen HLA. Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults: REVIEW: MANAGEMENT OF NON-CIRRHOTIC NON-MALIGNANT EPVT. Alimentary Pharmacology & Therapeutics 2007;26:203-9. [DOI: 10.1111/j.1365-2036.2007.03488.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
97 Li T, Zhai S, Pang Z, Ma X, Cao H, Bai W, Wang Z, Zhang WW. Feasibility and midterm outcomes of percutaneous transhepatic balloon angioplasty for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. J Vasc Surg 2009;50:1079-84. [PMID: 19703746 DOI: 10.1016/j.jvs.2009.06.049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
98 Italian Association for the Study of the Liver (AISF); Italian Association for the Study of the Liver AISF. AISF position paper on liver disease and pregnancy. Dig Liver Dis. 2016;48:120-137. [PMID: 26747754 DOI: 10.1016/j.dld.2015.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
99 Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC; European Group for the Study of Vascular Disorders of the Liver. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38:364-371. [PMID: 12586305 DOI: 10.1016/s0168-8278(02)00434-8] [Cited by in Crossref: 327] [Cited by in F6Publishing: 62] [Article Influence: 18.2] [Reference Citation Analysis]
100 Brandenburg VM, Frank RD, Wasmuth HE, Gartung C. Elevated levels of factor VIII:C as a possible risk factor for portal, splenic, and mesenteric vein thrombosis. Gastroenterology 2001;120:1563-4. [DOI: 10.1053/gast.2001.24506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
101 Berzigotti A, García-criado Á, Darnell A, García-pagán J. Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol 2014;11:308-16. [DOI: 10.1038/nrgastro.2013.258] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 6.9] [Reference Citation Analysis]
102 Mukund A, Gamanagatti S. Imaging and interventions in Budd-Chiari syndrome. World J Radiol. 2011;3:169–177. [PMID: 21860712 DOI: 10.4329/wjr.v3.i7.169] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
103 Sherid M, Samo S, Suliaman S, Gaziano JH. Acute Fulminant Form of Budd–Chiari Syndrome Secondary to Inferior Vena Cava Sarcoma: a Case Report and Review of the Literature. J Gastrointest Canc 2013;44:472-6. [DOI: 10.1007/s12029-012-9475-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Gairing SJ, Kloeckner R, Pitton MB, Baumgart J, von Auer-Wegener C, Lang H, Galle PR, Foerster F, Schattenberg JM. Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion. Z Gastroenterol 2021;59:43-9. [PMID: 33429449 DOI: 10.1055/a-1330-9827] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Poisson J, Plessier A, Kiladjian J, Turon F, Cassinat B, Andreoli A, De Raucourt E, Goria O, Zekrini K, Bureau C, Lorre F, Cervantes F, Colomer D, Durand F, Garcia-pagan J, Casadevall N, Valla D, Rautou P, Marzac C. Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study. Journal of Hepatology 2017;67:501-7. [DOI: 10.1016/j.jhep.2017.04.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 7.8] [Reference Citation Analysis]
106 Hoekstra J, Guimarães AHC, Leebeek FWG, Darwish Murad S, Malfliet JJMC, Plessier A, Hernandez-guerra M, Langlet P, Elias E, Trebicka J, Primignani M, Garcia-pagan J, Valla DC, Rijken DC, Janssen HLA; for the European Network for Vascular Disorders of the Liver (EN-Vie). Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome. Blood 2010;115:388-95. [DOI: 10.1182/blood-2009-03-211557] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
107 Kc D, Falchi L, Verstovsek S. The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review. Ann Hematol 2017;96:1595-604. [PMID: 28808761 DOI: 10.1007/s00277-017-3099-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
108 Dutta AK, Chacko A, George B, Joseph JA, Nair SC, Mathews V. Risk factors of thrombosis in abdominal veins. World J Gastroenterol. 2008;14:4518-4522. [PMID: 18680232 DOI: 10.3748/wjg.14.4518] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
109 Zimmerman MA, Cameron AM, Ghobrial RM. Budd-Chiari syndrome. Clin Liver Dis. 2006;10:259-273. [PMID: 16971261 DOI: 10.1016/j.cld.2006.05.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
110 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 132] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
111 Kida Y, Maeshima E, Yamada Y. Portal vein thrombosis in a patient with hepatitis C virus-related cirrhosis complicated with antiphospholipid syndrome. Rheumatol Int. 2009;29:1495-1498. [PMID: 19184031 DOI: 10.1007/s00296-009-0856-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
112 Akamatsu N, Sugawara Y, Kokudo N. Budd-Chiari syndrome and liver transplantation. Intractable Rare Dis Res. 2015;4:24-32. [PMID: 25674385 DOI: 10.5582/irdr.2014.01031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
113 Villagrán R, Smith G, Rodriguez W, Flores C, Cariaga M, Araya S, Yañez M, Fuentes P, Linares J, Zapata A. Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: Incidence, Analysis and Follow-Up in 1236 Consecutive Cases. Obes Surg 2016;26:2555-61. [PMID: 27079191 DOI: 10.1007/s11695-016-2183-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
114 Benjaminov FS, Heathcote J. Liver disease in pregnancy. Am J Gastroenterol. 2004;99:2479-2488. [PMID: 15571598 DOI: 10.1111/j.1572-0241.2004.30231.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
115 Rossetto V, Spiezia L, Senzolo M, Rodriguez-Castro KI, Gavasso S, Woodhams B, Simioni P. Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? Intern Emerg Med 2014;9:397-403. [PMID: 23504244 DOI: 10.1007/s11739-013-0929-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
116 Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2010;42:163-170. [PMID: 19766546 DOI: 10.1016/j.dld.2009.08.003] [Cited by in Crossref: 87] [Cited by in F6Publishing: 62] [Article Influence: 7.3] [Reference Citation Analysis]
117 Terreni N, Vangeli M, Raimondo ML, Tibballs JM, Patch D, Burroughs AK. Late intrahepatic hematoma complicating transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome. Cardiovasc Intervent Radiol. 2007;30:1065-1069. [PMID: 17546402 DOI: 10.1007/s00270-007-9067-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
118 Ikeda M, Sekimoto M, Takiguchi S, Yasui M, Danno K, Fujie Y, Kitani K, Seki Y, Hata T, Shingai T. Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment. Am J Surg. 2007;193:21-25. [PMID: 17188082 DOI: 10.1016/j.amjsurg.2006.06.036/] [Reference Citation Analysis]
119 Dumortier J, Walter T, Guillaud O, Pietu F, Vallin M, Henry L, Pilleul F. Transcatheter local thrombolysis in patients with extensive TIPS thrombosis. Gastroenterol Clin Biol. 2010;34:721-725. [PMID: 20934290 DOI: 10.1016/j.gcb.2010.07.011] [Reference Citation Analysis]
120 Goulding C, Uttenthal B, Foroni L, Duke V, Traore A, Kottaridis P, Hoffbrand AV, Patch D, McNamara C. The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis. Int J Lab Hematol. 2008;30:415-419. [PMID: 19046316 DOI: 10.1111/j.1751-553x.2007.00973.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
121 Suhocki PV, Lungren MP, Kapoor B, Kim CY. Transjugular intrahepatic portosystemic shunt complications: prevention and management. Semin Intervent Radiol. 2015;32:123-132. [PMID: 26038620 DOI: 10.1055/s-0035-1549376] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
122 Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008;111:4922-4929. [PMID: 18250227 DOI: 10.1182/blood-2007-11-125328] [Cited by in Crossref: 226] [Cited by in F6Publishing: 158] [Article Influence: 17.4] [Reference Citation Analysis]
123 Amitrano L, Guardascione MA, Schiavone EM, Brancaccio V, Antinolfi I, Iannaccone L, Ferrara F, Balzano A. Hepatic vein thrombosis leading to fulminant hepatic failure in a case of acute non-promyelocytic myelogenous leukemia. Blood Coagul Fibrinolysis 2006;17:59-61. [PMID: 16607082 DOI: 10.1097/01.mbc.0000198049.19763.09] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Harrison MF. The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting. West J Emerg Med. 2018;19:863-871. [PMID: 30202500 DOI: 10.5811/westjem.2018.7.37893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
125 Amitrano L, Guardascione MA, Scaglione M, Menchise A, Romano L, Balzano A. Acute portal and mesenteric thrombosis: unusual presentation of cytomegalovirus infection. Eur J Gastroenterol Hepatol 2006;18:443-5. [PMID: 16538119 DOI: 10.1097/00042737-200604000-00021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
126 Rathod K, Deshmukh H, Shukla A, Popat B, Pandey A, Gupte A, Gupta DK, Bhatia SJ. Endovascular treatment of Budd-Chiari syndrome: Single center experience. J Gastroenterol Hepatol. 2017;32:237-243. [PMID: 27218672 DOI: 10.1111/jgh.13456] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
127 Hoekstra J, Leebeek FW, Plessier A, Raffa S, Darwish Murad S, Heller J, Hadengue A, Chagneau C, Elias E, Primignani M. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study. J Hepatol. 2009;51:696-706. [PMID: 19664836 DOI: 10.1016/j.jhep.2009.06.019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
128 Shan H, Xiao XS, Huang MS, Ouyang Q, Jiang ZB. Portal venous stent placement for treatment of portal hypertension caused by benign main portal vein stenosis. World J Gastroenterol 2005;11:3315-8. [PMID: 15929192 DOI: 10.3748/wjg.v11.i21.3315] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
129 D'amico G, Tarantino G, Spaggiari M, Ballarin R, Serra V, Rumpianesi G, Montalti R, De Ruvo N, Cautero N, Begliomini B, Gerunda G, Di Benedetto F. Multiple Ways to Manage Portal Thrombosis During Liver Transplantation: Surgical Techniques and Outcomes. Transplantation Proceedings 2013;45:2692-9. [DOI: 10.1016/j.transproceed.2013.07.046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
130 Dumic I, Tankosic N, Stojkovic Lalosevic M, Alempijevic T. Sport-Related Portal Vein Thrombosis: An Unusual Complication. Case Reports Hepatol 2017;2017:9324246. [PMID: 29259831 DOI: 10.1155/2017/9324246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
131 DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 389] [Article Influence: 49.9] [Reference Citation Analysis]
132 Mcnamara C, Juneja S, Wolf M, Grigg A. Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts: Latent myeloproliferative disorder and thrombosis. Clinical & Laboratory Haematology 2002;24:239-42. [DOI: 10.1046/j.1365-2257.2002.00444.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
133 Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gäken J. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology. 2006;130:2031-2038. [PMID: 16762626 DOI: 10.1053/j.gastro.2006.04.008] [Cited by in Crossref: 192] [Cited by in F6Publishing: 138] [Article Influence: 12.8] [Reference Citation Analysis]
134 Uflacker R. Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis. Tech Vasc Interv Radiol. 2003;6:59-69. [PMID: 12772131 DOI: 10.1053/tvir.2003.36433] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
135 Muneer M, Abdelrahman H, El-Menyar A, Zarour A, Awad A, Al Dhaheri M, Al-Thani H. Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: 3 Case Reports and a Literature Review. Am J Case Rep 2016;17:241-7. [PMID: 27068354 DOI: 10.12659/ajcr.896892] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 3.8] [Reference Citation Analysis]
136 Regina S, Herault O, D'alteroche L, Binet C, Gruel Y. JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. J Thromb Haemost 2007;5:859-61. [DOI: 10.1111/j.1538-7836.2007.02384.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
137 Ikeda M, Sekimoto M, Takiguchi S, Yasui M, Danno K, Fujie Y, Kitani K, Seki Y, Hata T, Shingai T. Total splenic vein thrombosis after laparoscopic splenectomy: a possible candidate for treatment. Am J Surg. 2007;193:21-25. [PMID: 17188082 DOI: 10.1016/j.amjsurg.2006.06.036] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
138 Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881-894. [PMID: 19678814 DOI: 10.1111/j.1365-2036.2009.04116.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
139 Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83-90. [PMID: 16405538 DOI: 10.1111/j.1572-0241.2006.00353.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
140 Julapalli VR, Bray PF, Duchini A. Elevated factor VIII and portal vein thrombosis. Dig Dis Sci 2003;48:2369-71. [PMID: 14714627 DOI: 10.1023/b:ddas.0000007877.17861.0a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
141 Afredj N, Metatla S, Faraoun SA, Nani A, Guessab N, Benhalima M, Bendib SE, Debzi N, Layaida K, Gamar L, Baiod N, Balamane M, Kaddache N, Bounab N, Kecili L, Boucekkine T. Association of Budd-Chiari syndrome and celiac disease. Gastroenterol Clin Biol 2010;34:621-4. [PMID: 20934289 DOI: 10.1016/j.gcb.2010.07.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
142 Jung HJ, Lee SS. Combination of Surgical Thrombectomy and Direct Thrombolysis in Acute Abdomen with Portal and Superior Mesenteric Vein Thrombosis. Vasc Specialist Int 2014;30:155-8. [PMID: 26217636 DOI: 10.5758/vsi.2014.30.4.155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Alzubaidi S, Patel I, Saini A, Knuttinen G, Naidu S, Kriegshuaser S, Albadawi H, Oklu R. Current concepts in portal vein thrombosis: etiology, clinical presentation and management. Abdom Radiol 2019;44:3453-62. [DOI: 10.1007/s00261-019-02174-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
144 Mirkovic D, Stankovic N, Jevtic M, Mitrovic M, Jovanovic M. Mesoatrial shunt in Budd-Chiari syndrome. VSP 2009;66:69-73. [DOI: 10.2298/vsp0901069m] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
145 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 53] [Article Influence: 39.5] [Reference Citation Analysis]
146 Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl. 2013;19:852-861. [PMID: 23696318 DOI: 10.1002/lt.23668] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 10.3] [Reference Citation Analysis]
147 Spaander MCW, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FWG, Janssen HLA. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 2013;11:452-9. [DOI: 10.1111/jth.12121] [Cited by in Crossref: 62] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
148 Sutkowska E, McBane RD, Tafur AJ, Sutkowski K, Grill DE, Slusser JP, Wysokinski WE. Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America. J Gastroenterol 2013;48:1111-8. [PMID: 23247829 DOI: 10.1007/s00535-012-0728-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
149 Manzanares J, Urruzuno P, Manzano M, Garfia C, Yela C, Castellano G, Solís J. Enfermedad celíaca y síndrome de Budd-Chiari: una asociación infrecuente. Gastroenterología y Hepatología 2002;25:159-61. [DOI: 10.1016/s0210-5705(02)79011-0] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
150 Fiorini A, Chiusolo P, Rossi E, Za T, De Ritis DG, Ciminello A, Leone G, De Stefano V. Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol 2009;84:126-7. [DOI: 10.1002/ajh.21335] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
151 Condat B, Vilgrain V, Asselah T, O’Toole D, Rufat P, Zappa M, Moreau R, Valla D. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302-1308. [PMID: 12774008 DOI: 10.1053/jhep.2003.50232] [Cited by in Crossref: 139] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
152 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Singhal D, de Castro S, Goyal N, Gouma DJ, Chaudhary A, van Gulik TM. Current role of portosystemic shunt surgery in the management of hepatic venous outflow obstruction. Dig Surg 2006;23:358-69. [PMID: 17164547 DOI: 10.1159/000097897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
154 Sekhar M, McVinnie K, Burroughs AK. Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 2013;162:730-47. [PMID: 23855810 DOI: 10.1111/bjh.12461] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
155 Ogren M, Bergqvist D, Björck M, Acosta S, Sternby NH. High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsies. J Thromb Haemost 2007;5:198-200. [PMID: 17059416 DOI: 10.1111/j.1538-7836.2006.02264.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
156 Galloula A, Rossi A, Gautier V, Minozzi C, Messas E, Mirault T. Thrombose portale associée à une infection aiguë à cytomégalovirus. Journal des Maladies Vasculaires 2014;39:224-30. [DOI: 10.1016/j.jmv.2014.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
157 Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. [PMID: 17697371 DOI: 10.1186/1471-230x-7-34/] [Reference Citation Analysis]
158 Walker AP. Portal vein thrombosis: what is the role of genetics?: . European Journal of Gastroenterology & Hepatology 2005;17:705-7. [DOI: 10.1097/01.meg.0000170927.60979.1d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
159 Janssen HL. Role of coagulation in the natural history and treatment of portal vein thrombosis. J Gastroenterol Hepatol 2001;16:595-6. [DOI: 10.1046/j.1440-1746.2001.02498.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
160 Cura M, Haskal Z, Lopera J. Diagnostic and interventional radiology for Budd-Chiari syndrome. Radiographics. 2009;29:669-681. [PMID: 19448109 DOI: 10.1148/rg.293085056] [Cited by in Crossref: 72] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
161 Vergniol J, Laharie D, Drouillard J, Etienne G, Pigneux A, Plessier A, Couzigou P, L??dinghen VD. Paroxysmal nocturnal hemoglobinuria and Budd???Chiari syndrome: therapeutic challenge with bone marrow transplantation, transjugular intrahepatic portosystemic shunt, and vena cava stent: . European Journal of Gastroenterology & Hepatology 2005;17:453-6. [DOI: 10.1097/00042737-200504000-00011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
162 Akbaş T, İmeryüz N, Bayalan F, Baltacıoğlu F, Atagündüz P, Mülazımoğlu L, Direskeneli H. A case of Budd–Chiari syndrome with Behcet’s disease and oral contraceptive usage. Rheumatol Int 2007;28:83-6. [DOI: 10.1007/s00296-007-0377-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
163 Núñez O, de la Cruz G, Molina J, Borrego GM, Marín I, Ponferrada A, Catalina V, Echenagusia A, Bañares R. [Interventional radiology, angioplasty and TIPS in Budd-Chiari syndrome]. Gastroenterol Hepatol 2003;26:461-4. [PMID: 14534016 DOI: 10.1016/s0210-5705(03)70394-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
164 Seedial SM, Mouli SK, Desai KR. Acute Portal Vein Thrombosis: Current Trends in Medical and Endovascular Management. Semin Intervent Radiol. 2018;35:198-202. [PMID: 30087523 DOI: 10.1055/s-0038-1660798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
165 Vibert É, Azoulay D, Castaing D, Bismuth H. Le cavernome portal : diagnostic, étiologies et conséquences. Annales de Chirurgie 2002;127:745-50. [DOI: 10.1016/s0003-3944(02)00897-0] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
166 Rössle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery. 2004;135:394-403. [PMID: 15041963 DOI: 10.1016/j.surg.2003.09.005] [Cited by in Crossref: 113] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]
167 Ventura P, Venturelli G, Marcacci M, Fiorini M, Marchini S, Cuoghi C, Pietrangelo A. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis. Thromb Res. 2016;141:189-195. [PMID: 27065203 DOI: 10.1016/j.thromres.2016.03.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
168 Michiels JJ, Commandeur S, Hoogenboom GJ, Wegman JJ, Scholten L, van Rijssel RH, De Raeve H. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature. Ann Hematol. 2007;86:793-800. [PMID: 17687555 DOI: 10.1007/s00277-007-0351-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
169 Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210-218. [PMID: 19821530 DOI: 10.1002/hep.23259] [Cited by in Crossref: 297] [Cited by in F6Publishing: 197] [Article Influence: 27.0] [Reference Citation Analysis]
170 Elkrief L, Corcos O, Bruno O, Larroque B, Rautou PE, Zekrini K, Bretagnol F, Joly F, Francoz C, Bondjemah V, Cazals-Hatem D, Boudaoud L, De Raucourt E, Panis Y, Goria O, Hillaire S, Valla D, Plessier A. Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis. Liver Int. 2014;34:1314-1321. [PMID: 24237969 DOI: 10.1111/liv.12386] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
171 Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490-497. [PMID: 11159889 DOI: 10.1053/gast.2001.21209] [Cited by in Crossref: 322] [Cited by in F6Publishing: 242] [Article Influence: 16.1] [Reference Citation Analysis]
172 Harmanci O, Ersoy O, Gurgey A, Buyukasik Y, Gedikoglu G, Balkanci F, Sivri B, Bayraktar Y. The Etiologic Distribution of Thrombophilic Factors in Chronic Portal Vein Thrombosis. Journal of Clinical Gastroenterology 2007;41:521-7. [DOI: 10.1097/01.mcg.0000225635.52780.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
173 Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, Marrero JA, Pelletier SJ. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16:83-90. [PMID: 20035521 DOI: 10.1002/lt.21941] [Cited by in Crossref: 146] [Cited by in F6Publishing: 125] [Article Influence: 13.3] [Reference Citation Analysis]
174 Jain A, Dhore P, Meshram M, Bhatia S, Shukla A. Patients With Budd-Chiari Syndrome Have Variable Coagulation Status on Thromboelastography at Diagnosis. J Clin Exp Hepatol. 2019;9:460-467. [PMID: 31516262 DOI: 10.1016/j.jceh.2018.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 Yesilova AM, Yavuzer S, Yavuzer H, Cengiz M, Toprak ID, Hanedar E, Ar MC, Baslar Z. Analysis of thrombosis and bleeding complications in patients with polycythemia vera: a Turkish retrospective study. Int J Hematol 2017;105:70-8. [DOI: 10.1007/s12185-016-2105-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
176 Winslow ER, Brunt LM, Drebin JA, Soper NJ, Klingensmith ME. Portal vein thrombosis after splenectomy. Am J Surg. 2002;184:631-635; discussion 635-636. [PMID: 12488196 DOI: 10.1016/s0002-9610(02)01095-4] [Cited by in Crossref: 118] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
177 Hintenberger R, Falkinger A, Danninger K, Pieringer H. Cardiovascular disease in patients with autoinflammatory syndromes. Rheumatol Int 2018;38:37-50. [DOI: 10.1007/s00296-017-3854-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
178 Neumann AB, Andersen SD, Nielsen DT, Holland-Fischer P, Vilstrup H, Grønbæk H. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt. World J Hepatol 2013;5:38-42. [PMID: 23383365 DOI: 10.4254/wjh.v5.i1.38] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
179 Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691-7. [PMID: 15831918 DOI: 10.1136/gut.2004.042796] [Cited by in Crossref: 351] [Cited by in F6Publishing: 272] [Article Influence: 21.9] [Reference Citation Analysis]
180 Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, Denninger MH, Durand F, Bedossa P, Valla DC. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol. 2011;54:455-461. [PMID: 21087805 DOI: 10.1016/j.jhep.2010.07.038] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 7.7] [Reference Citation Analysis]
181 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Hematology/Oncology Clinics of North America 2011;25:1049-66. [DOI: 10.1016/j.hoc.2011.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
182 Qi T, Zhu C, Lu G, Hao J, He Q, Chen Y, Zhou F, Chen J, Hou J. Elevated D-dimer is associated with increased 28-day mortality in acute-on-chronic liver failure in China: a retrospective study. BMC Gastroenterol 2019;19:20. [PMID: 30704397 DOI: 10.1186/s12876-019-0941-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
183 Wani ZA, Bhat RA, Bhadoria AS, Maiwall R. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification. Saudi J Gastroenterol 2015;21:129-38. [PMID: 26021771 DOI: 10.4103/1319-3767.157550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
184 Nasim M, Majid B, Tahir F, Majid Z, Irfan I. Cavernous Transformation of Portal Vein in the Setting of Protein C and Anti-thrombin III Deficiency. Cureus. 2019;11:e5779. [PMID: 31723538 DOI: 10.7759/cureus.5779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Karoui S, Sfar S, Kallel M, Boubaker J, Makni S, Filali A. [Antiphospholipid syndrome revealed by portal vein thrombosis in a patient with celiac disease]. Rev Med Interne. 2004;25:471-473. [PMID: 15158321 DOI: 10.1016/j.revmed.2004.02.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
186 Hoekstra J, Seijo S, Rautou P, Ducarme G, Boudaoud L, Luton D, Alijotas-reig J, Casellas-caro M, Condat B, Bresser E, Thabut D, Larroque B, Gárcia-pagán J, Janssen H, Valla D, Plessier A. Pregnancy in women with portal vein thrombosis: Results of a multicentric European study on maternal and fetal management and outcome. Journal of Hepatology 2012;57:1214-9. [DOI: 10.1016/j.jhep.2012.07.034] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
187 Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg. 2005;241:208-216. [PMID: 15650628 DOI: 10.1097/01.sla.0000151794.28392.a6/] [Reference Citation Analysis]
188 Yoo E, Jang J, Park K, Gwak G, Kim H, Kim S, Kim D. Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis: THE JAK2 V617F MUTATION IN KOREAN PATIENTS WITH SVT. International Journal of Laboratory Hematology 2011. [DOI: 10.1111/j.1751-553x.2011.01308.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
189 Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg. 2010;251:76-83. [PMID: 19864937 DOI: 10.1097/sla.0b013e3181bdf8ad] [Cited by in Crossref: 79] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
190 Colaizzo D, Amitrano L, Guardascione MA, Balzano A, Margaglione M. Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis: . European Journal of Gastroenterology & Hepatology 2008;20:245-6. [DOI: 10.1097/meg.0b013e3282f1cff7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
191 Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, Leandro G, Caruso N, Andriulli A. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol. 2005;17:745-751. [PMID: 15947552 DOI: 10.1097/00042737-200507000-00009] [Cited by in Crossref: 62] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
192 Burroughs AK. The Hepatic Artery, Portal Venous System and Portal Hypertension: The Hepatic Veins and Liver in Circulatory Failure. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 152-209. [DOI: 10.1002/9781444341294.ch9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
193 Rodriguez-luna H, Vargas HE. Portal and Splenic Vein Thrombosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 905-14. [DOI: 10.1016/b978-1-4160-3258-8.50052-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
194 Murad SD, Kamath PS. Liver transplantation for Budd-Chiari syndrome: When is it really necessary? Liver Transpl 2008;14:133-5. [DOI: 10.1002/lt.21286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
195 Haliloglu N, Erden A. Hepatic venous outflow obstruction after hydatid cyst surgery: evaluation with contrast enhanced magnetic resonance angiography. Eur J Gastroenterol Hepatol. 2009;21:776-780. [PMID: 19829170 DOI: 10.1097/meg.0b013e328305b9f3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
196 Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: Three similar syndromes. World J Gastroenterol. 2007;13:1912-1927. [PMID: 17461490 DOI: 10.3748/wjg.v13.i13.1912] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
197 Wang H, Sun G, Zhang P, Zhang J, Gui E, Zu M, Jia E, Xu H, Xu L, Zhang J, Lu Z. JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients: JAK2 rs12343867 in Budd-Chiari syndrome. J Gastroenterol Hepatol 2014;29:208-14. [DOI: 10.1111/jgh.12379] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
198 Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood 2008;112:4818-23. [DOI: 10.1182/blood-2008-07-165969] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
199 Vianna R, Giovanardi RO, Fridell JA, Tector AJ. Multivisceral transplantation for diffuse portomesenteric thrombosis in a patient with life-threatening esophagogastroduodenal bleeding. Transplantation 2005;80:534-5. [PMID: 16123730 DOI: 10.1097/01.tp.0000168344.16547.da] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
200 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
201 Senzolo M, Riggio O, Primignani M; Italian Association for the Study of the Liver (AISF) ad hoc. Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. Dig Liver Dis. 2011;43:503-514. [PMID: 21185794 DOI: 10.1016/j.dld.2010.11.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
202 Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384-93. [DOI: 10.1002/hep.22192] [Cited by in Crossref: 77] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
203 Decaens T, Maitre S, Marfaing A, Naveau S, Chaput J, Mathurin P. Maladie inflammatoire cryptogénétique de l’intestin et thrombocytémie latente : nouvelle étiologie de thrombose des veines hépatiques ? Gastroentérologie Clinique et Biologique 2004;28:394-7. [DOI: 10.1016/s0399-8320(04)94941-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
204 Seijo S, Garcia-pagan JC. An overview of current treatment methods for Budd–Chiari syndrome. Expert Opinion on Orphan Drugs 2014;2:147-57. [DOI: 10.1517/21678707.2014.872560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Aydinli M, Bayraktar Y. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007;13:2693-2696. [PMID: 17569137 DOI: 10.3748/wjg.v13.i19.2693] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
206 Elsayes KM, Shaaban AM, Rothan SM, Javadi S, Madrazo BL, Castillo RP, Casillas VJ, Menias CO. A Comprehensive Approach to Hepatic Vascular Disease. RadioGraphics 2017;37:813-36. [DOI: 10.1148/rg.2017160161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
207 Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR, Janssen HL. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39:500-508. [PMID: 14768004 DOI: 10.1002/hep.20064] [Cited by in Crossref: 234] [Cited by in F6Publishing: 158] [Article Influence: 13.8] [Reference Citation Analysis]
208 Montano-Loza AJ, Tandon P, Kneteman N, Bailey R, Bain VG. Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival. Aliment Pharmacol Ther. 2009;30:1060-1069. [PMID: 19723029 DOI: 10.1111/j.1365-2036.2009.04134.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
209 Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015;45:656-662. [PMID: 25088236 DOI: 10.1111/hepr.12400] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
210 Spanier BW, Frederiks J. Aetiology of extrahepatic portal vein thrombosis. Gut. 2002;51:755-756; author reply 756. [PMID: 12377821 DOI: 10.1136/gut.51.5.755-b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
211 Eleftheriadis N, Makris P. Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden. Ther Clin Risk Manag 2010;6:539-41. [PMID: 21127694 DOI: 10.2147/TCRM.S13660] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
212 Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421-441. [PMID: 23978714 DOI: 10.1016/j.jhep.2013.08.013] [Cited by in Crossref: 170] [Cited by in F6Publishing: 100] [Article Influence: 21.3] [Reference Citation Analysis]
213 Ferri PM, Ferreira AR, Fagundes ED, Liu SM, Roquete ML, Penna FJ. Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center. Arq Gastroenterol 2012;49:69-76. [PMID: 22481689 DOI: 10.1590/s0004-28032012000100012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
214 Sommacale D, Palladino E, Tamby EL, Diebold MD, Kianmanesh AR. Spontaneous hepatic rupture in a patient with peliosis hepatis: A report of one case. Int J Surg Case Rep. 2013;4:508-510. [PMID: 23562904 DOI: 10.1016/j.ijscr.2013.01.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
215 Huang L, Yu Q, Peng H. Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy. Med Sci Monit 2021;27:e931157. [PMID: 34120137 DOI: 10.12659/MSM.931157] [Reference Citation Analysis]
216 Fallon MB, Batra S. Inherited thrombophilia and the risk of portal vein thrombosis: progress toward individualized anticoagulation in cirrhosis? Clin Gastroenterol Hepatol 2014;12:1813-4. [PMID: 25086188 DOI: 10.1016/j.cgh.2014.07.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
217 Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell’Era A, Bucciarelli P, Mannucci PM. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006;44:1528-1534. [PMID: 17133457 DOI: 10.1002/hep.21435] [Cited by in Crossref: 176] [Cited by in F6Publishing: 135] [Article Influence: 12.6] [Reference Citation Analysis]
218 Squizzato A, Ageno W, Cattaneo A, Brumana N. A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 2007;44:e13-e16. [PMID: 17173209 DOI: 10.1086/509641] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
219 Vassiliadis T, Mpoumponaris A, Giouleme O, Hatzidakis A, Patsiaoura K, Zezos P, Vakalopoulou S, Kargiotis K, Gkisakis D, Katsinelos P, Evgenidis N. Late onset ulcerative colitis complicating a patient with Budd-Chiari syndrome: a case report and review of the literature. Eur J Gastroenterol Hepatol 2009;21:109-13. [PMID: 19060635 DOI: 10.1097/MEG.0b013e32830263cb] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
220 Geri G, Saadoun D, Cacoub P. Manifestations hépatiques des maladies systémiques. La Revue de Médecine Interne 2011;32:486-93. [DOI: 10.1016/j.revmed.2010.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
221 Rosenblatt R, Brown RS. Nonviral or Drug-Induced Etiologies of Acute Liver Failure. Clinics in Liver Disease 2018;22:347-60. [DOI: 10.1016/j.cld.2018.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
222 Buckley O, O’ Brien J, Snow A, Stunell H, Lyburn I, Munk PL, Torreggiani WC. Imaging of Budd-Chiari syndrome. Eur Radiol. 2007;17:2071-2078. [PMID: 17206425 DOI: 10.1007/s00330-006-0537-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
223 You H, Zhao J, Huang C, Tian X, Li M, Zeng X. Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis. Front Med (Lausanne) 2021;8:630660. [PMID: 33614687 DOI: 10.3389/fmed.2021.630660] [Reference Citation Analysis]
224 Papadakis E, Hoffman R, Brenner B. Thrombohemorrhagic complications of myeloproliferative disorders. Blood Reviews 2010;24:227-32. [DOI: 10.1016/j.blre.2010.08.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
225 De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, Leone G. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost. 2007;5:708-714. [PMID: 17263783 DOI: 10.1111/j.1538-7836.2007.02424.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 105] [Article Influence: 9.6] [Reference Citation Analysis]
226 Amitrano L, Guardascione MA, Ames PR, Margaglione M, Antinolfi I, Iannaccone L, Annunziata M, Ferrara F, Brancaccio V, Balzano A. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol 2003;72:75-81. [PMID: 12555209 DOI: 10.1002/ajh.10254] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
227 Xavier SG, Gadelha T, Pimenta G, Eugenio AM, Ribeiro DD, Gomes FM, Bonamino M, Zalcberg IR, Spector N. JAK2V617F mutation in patients with splanchnic vein thrombosis. Dig Dis Sci. 2010;55:1770-1777. [PMID: 19690956 DOI: 10.1007/s10620-009-0933-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
228 Klein A. Surgical treatment of Budd-Chiari syndrome. Liver Transplantation 2003;9:891-6. [DOI: 10.1053/jlts.2003.50156] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
229 Aomar Millán IF, Pérez Fernández L, Parejo Sánchez MI, Hernández Quero J. Hepatitis aguda por citomegalovirus como causa de trombosis portal y mesentérica. Medicina Clínica 2010;135:338-9. [DOI: 10.1016/j.medcli.2009.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
230 Posada-Arango AM, García-Madrigal J, Echeverri-Isaza S, Alberto-Castrillón G, Martínez D, Gómez AC, Pinto JA, Pinillos L. Thrombosis in abdominal vessels associated with COVID-19 Infection: A report of three cases. Radiol Case Rep 2021;16:3044-50. [PMID: 34306276 DOI: 10.1016/j.radcr.2021.07.032] [Reference Citation Analysis]
231 Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis. 2009;1:e2009014. [PMID: 21415954 DOI: 10.4084/mjhid.2009.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
232 Rautou PE, Angermayr B, Garcia-Pagan JC, Moucari R, Peck-Radosavljevic M, Raffa S, Bernuau J, Condat B, Levardon M, Yver C. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol. 2009;51:47-54. [PMID: 19443069 DOI: 10.1016/j.jhep.2009.02.028] [Cited by in Crossref: 58] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
233 Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16:999-1005. [PMID: 20677291 DOI: 10.1002/lt.22105] [Cited by in Crossref: 147] [Cited by in F6Publishing: 106] [Article Influence: 13.4] [Reference Citation Analysis]
234 Gonzalez F, Condat B, Deltenre P, Mathurin P, Paris J, Dharancy S. Extensive portal vein thrombosis related to abdominal trauma. Gastroentérologie Clinique et Biologique 2006;30:314-6. [DOI: 10.1016/s0399-8320(06)73173-6] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
235 Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Brière J, Erlinger S, Valla DC. Factor V Leiden related Budd-Chiari syndrome. Gut. 2001;48:264-268. [PMID: 11156651 DOI: 10.1136/gut.48.2.264] [Cited by in Crossref: 114] [Cited by in F6Publishing: 79] [Article Influence: 5.7] [Reference Citation Analysis]
236 Francque S, Condat B, Asselah T, Vilgrain V, Durand F, Moreau R, Valla D. Multifactorial aetiology of hepatic infarction: a case report with literature review. Eur J Gastroenterol Hepatol. 2004;16:411-415. [PMID: 15028975 DOI: 10.1097/00042737-200404000-00008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
237 Berzigotti A, Frigato M, Manfredini E, Pierpaoli L, Mulè R, Tiani C, Zappoli P, Magalotti D, Malavolta N, Zoli M. Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. World J Gastroenterol 2011;17:4503-8. [PMID: 22110281 DOI: 10.3748/wjg.v17.i40.4503] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
238 Martens P, Nevens F. Budd-Chiari syndrome. United European Gastroenterol J. 2015;3:489-500. [PMID: 26668741 DOI: 10.1177/2050640615582293] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 7.8] [Reference Citation Analysis]
239 Orr DW, Patel RK, Lea NC, Westbrook RH, O'Grady JG, Heaton ND, Pagliuca A, Mufti GJ, Heneghan MA. The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther 2010;31:1330-6. [PMID: 20331577 DOI: 10.1111/j.1365-2036.2010.04299.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
240 Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006;12:1165-1174. [PMID: 16534866 DOI: 10.3748/wjg.v12.i8.1165] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
241 Stefano VD, Fiorini A, Rossi E, Za T, Chiusolo P, Sica S, Leone G. High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis. Hepatology 2007;45:831-2. [DOI: 10.1002/hep.21601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
242 Thorburn D, Stanley AJ, Foulis A, Campbell Tait R. Coeliac disease presenting as variceal haemorrhage. Gut 2003;52:758. [PMID: 12692066 DOI: 10.1136/gut.52.5.758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
243 Hiroe S, Itoh H, Matsumoto H, Takahasi S, Sato Y, Yamada S, Okagaki A, Kuzushita N, Ban C. Case of Budd-Chiari syndrome 3 months after vaginal delivery. J Obstet Gynaecol Res 2008;34:605-8. [PMID: 18840163 DOI: 10.1111/j.1447-0756.2008.00893.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
244 Wobser H, Schölmerich J, Büttner R. [19-year-old kick-boxer with hematemesis and splenomegaly]. Internist (Berl) 2010;51:213-8. [PMID: 19771406 DOI: 10.1007/s00108-009-2446-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
245 Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol. 2008;14:278-285. [PMID: 18186568 DOI: 10.3748/wjg.14.278] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
246 Bissonnette J, Durand F, de Raucourt E, Ceccaldi PF, Plessier A, Valla D, Rautou PE. Pregnancy and vascular liver disease. J Clin Exp Hepatol 2015;5:41-50. [PMID: 25941432 DOI: 10.1016/j.jceh.2014.12.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
247 Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006;107:4214-22. [DOI: 10.1182/blood-2005-08-3526] [Cited by in Crossref: 101] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
248 Qi X, Wu F, Ren W, He C, Yin Z, Niu J, Bai M, Yang Z, Wu K, Fan D. Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost. 2013;109:878-884. [PMID: 23447059 DOI: 10.1160/th12-10-0784] [Cited by in Crossref: 56] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
249 Heller C, Schobess R, Kurnik K, Junker R, Günther G, Kreuz W, Nowak-Göttl U. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. Br J Haematol 2000;111:534-9. [PMID: 11122096 DOI: 10.1046/j.1365-2141.2000.02349.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
250 Brancaccio V, Iannaccone L, Margaglione M, Guardascione MA, Amitrano L. Multiple thrombophilic factors in a patient with Budd-Chiari syndrome: Budd-Chiari thrombophilic factors. Clinical & Laboratory Haematology 2002;24:61-3. [DOI: 10.1046/j.1365-2257.2002.00196.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
251 Tateishi A, Mitsui H, Oki T, Morishita J, Maekawa H, Yahagi N, Maruyama T, Ichinose M, Ohnishi S, Shiratori Y. Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation. J Gastroenterol Hepatol. 2001;16:1429-1433. [PMID: 11851847 DOI: 10.1046/j.1440-1746.2001.02557.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
252 Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant 2005;19:501-6. [DOI: 10.1111/j.1399-0012.2005.00374.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
253 Menezes Ferri P, Rodrigues Ferreira A, Tavares Fagundes ED, Guerra Xavier S, Dias Ribeiro D, Fernandes AP, Gomes Borges KB, Liu SM, de Melo MDCB, Roquete MLV, Penna FJ. Evaluation of the Presence of Hereditary and Acquired Thrombophilias in Brazilian Children and Adolescents With Diagnoses of Portal Vein Thrombosis. Journal of Pediatric Gastroenterology & Nutrition 2012;55:599-604. [DOI: 10.1097/mpg.0b013e318261814d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
254 Sacerdoti D, Serianni G, Gaiani S, Bolognesi M, Bombonato G, Gatta A. Thrombosis of the portal venous system. J Ultrasound 2007;10:12-21. [PMID: 23396402 DOI: 10.1016/j.jus.2007.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
255 Poreddy V, Deleve LD. Hepatic circulatory diseases associated with chronic myeloid disorders. Clinics in Liver Disease 2002;6:909-31. [DOI: 10.1016/s1089-3261(02)00051-x] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
256 Hibi A, Mogi K. Portal vein thrombosis after cesarean section in a patient on prolonged bed rest due to threatened preterm labor. Clin Case Rep 2018;6:531-6. [PMID: 29531735 DOI: 10.1002/ccr3.1405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
257 Plessier A, Valla D. Syndrome de Budd-Chiari. EMC - Hépatologie 2006;1:1-9. [DOI: 10.1016/s1155-1976(06)41408-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
258 Valla D, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West: Portal vein thrombosis in the West. Journal of Gastroenterology and Hepatology 2002;17:S224-7. [DOI: 10.1046/j.1440-1746.17.s3.4.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
259 Vayá A, Plumé G, Bonet E, Carrasco P, Morales-suárez-varela MM. Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis: Hyperhomocysteinemia and MTHFR mutation. European Journal of Haematology 2011;86:167-72. [DOI: 10.1111/j.1600-0609.2010.01551.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
260 Sharma A, Keshava SN, Eapen A, Elias E, Eapen CE. An Update on the Management of Budd-Chiari Syndrome. Dig Dis Sci 2021;66:1780-90. [PMID: 32691382 DOI: 10.1007/s10620-020-06485-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int. 2018;12:168-180. [PMID: 28685257 DOI: 10.1007/s12072-017-9810-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
262 Manatsathit W, Patel K, Enke T, Sayles H, Jophlin LL, Merani S. Increased Morbidity and Mortality of Patients with Non-cirrhotic Portal Vein Thrombosis After Abdominal and Pelvic Surgeries: a Study of the National Inpatient Sample 2002 to 2015. J Gastrointest Surg 2021;25:2026-34. [PMID: 33037558 DOI: 10.1007/s11605-020-04818-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Pelizzo G, Quaretti P, Moramarco LP, Corti R, Maestri M, Iacob G, Calcaterra V. One step minilaparotomy-assisted transmesenteric portal vein recanalization combined with transjugular intrahepatic portosystemic shunt placement: A novel surgical proposal in pediatrics. World J Gastroenterol 2017;23:2811-8. [PMID: 28487619 DOI: 10.3748/wjg.v23.i15.2811] [Cited by in CrossRef: 2] [Article Influence: 0.7] [Reference Citation Analysis]
264 Rebours V, Boudaoud L, Vullierme MP, Vidaud D, Condat B, Hentic O, Maire F, Hammel P, Ruszniewski P, Lévy P. Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia. Am J Gastroenterol. 2012;107:1579-1585. [PMID: 22825367 DOI: 10.1038/ajg.2012.231] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
265 Louvet A, Texier F, Dharancy S, Pruvot FR, Sergent G, Deltenre P, Ernst O, Paris JC, Mathurin P. Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis. Dig Dis Sci 2006;51:11-7. [PMID: 16416202 DOI: 10.1007/s10620-006-3075-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
266 Fan J, Wang Q, Luo B, Chen H, Wang Z, Niu J, Yuan J, Yuan X, Bai W, He C, Guo W, Li K, Yin Z, Fan D, Han G. Prevalence of prothrombotic factors in patients with Budd–Chiari syndrome or non‐cirrhotic nonmalignant portal vein thrombosis: A hospital‐based observational study. Journal of Gastroenterology and Hepatology 2020;35:1215-22. [DOI: 10.1111/jgh.14925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
267 Shetty S, Ghosh K. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review. Thrombosis Research 2011;127:505-12. [DOI: 10.1016/j.thromres.2010.09.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
268 Breccia M, Morano SG, D'andrea M, Russo E, D'elia GM, Alimena G. Budd-Chiari syndrome as the first manifestation of polycythemia vera in young women with inherited thrombophilic state: an aggressive form of myeloproliferative disorder requiring multidisciplinary management. Eur J Haematol 2005;75:396-400. [DOI: 10.1111/j.1600-0609.2005.00522.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
269 Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Rev Gastroenterol Hepatol 2006;3:505-15. [DOI: 10.1038/ncpgasthep0577] [Cited by in Crossref: 76] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
270 Perelló A, García-Pagán JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, Reverter JC, Escorsell A, Bosch J, Rodés J. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132-139. [PMID: 11786969 DOI: 10.1053/jhep.2002.30274] [Cited by in Crossref: 154] [Cited by in F6Publishing: 118] [Article Influence: 8.1] [Reference Citation Analysis]
271 Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, Mancuso A, Zhang W, Han X. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China. Aliment Pharmacol Ther. 2016;44:1152-1167. [PMID: 27734511 DOI: 10.1111/apt.13815] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 8.2] [Reference Citation Analysis]
272 Condat B. Thrombose de la veine porte. Gastroentérologie Clinique et Biologique 2006;30:1170-6. [DOI: 10.1016/s0399-8320(06)73496-0] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
273 Rodrigues SG, Maurer MH, Baumgartner I, De Gottardi A, Berzigotti A. Imaging and minimally invasive endovascular therapy in the management of portal vein thrombosis. Abdom Radiol (NY). 2018;43:1931-1946. [PMID: 28983654 DOI: 10.1007/s00261-017-1335-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
274 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
275 Karaosmanoglu AD, Uysal A, Akata D, Ozmen MN, Karcaaltincaba M. Role of imaging in visceral vascular emergencies. Insights Imaging 2020;11:112. [PMID: 33057847 DOI: 10.1186/s13244-020-00913-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Ladd AM, Goyal R, Rosainz L, Baiocco P, DiFabrizio L. Pulmonary embolism and portal vein thrombosis in an immunocompetent adolescent with acute cytomegalovirus hepatitis. J Thromb Thrombolysis. 2009;28:496-499. [PMID: 19116696 DOI: 10.1007/s11239-008-0303-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
277 Palandri F, Mora B, Gangat N, Catani L. Is there a gender effect in polycythemia vera? Ann Hematol 2021;100:11-25. [PMID: 33006021 DOI: 10.1007/s00277-020-04287-w] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
278 Perez-johnston R, Lenhart DK, Sahani DV. CT Angiography of the Hepatic and Pancreatic Circulation. Radiologic Clinics of North America 2010;48:311-30. [DOI: 10.1016/j.rcl.2010.02.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
279 Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:318-65. [PMID: 32946672 DOI: 10.1002/hep.31559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
280 Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell’Era A, Mannucci PM. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol. 2009;50:916-922. [PMID: 19304336 DOI: 10.1016/j.jhep.2008.12.020] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
281 Cohen R, Mallet T, Gale M, Soltys R, Loarte P. Portal vein thrombosis. Case Rep Vasc Med 2015;2015:823063. [PMID: 25802795 DOI: 10.1155/2015/823063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
282 Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol. 2008;25:92-103. [PMID: 21326550 DOI: 10.1055/s-2008-1076679] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
283 Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson Å, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience. Liver International 2009;29:253-9. [DOI: 10.1111/j.1478-3231.2008.01838.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
284 Saadoun D, Cazals-Hatem D, Denninger MH, Boudaoud L, Pham BN, Mallet V, Condat B, Brière J, Valla D. Association of idiopathic hepatic sinusoidal dilatation with the immunological features of the antiphospholipid syndrome. Gut 2004;53:1516-9. [PMID: 15361506 DOI: 10.1136/gut.2003.037135] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
285 Puccia F, Lombardo V, Giannitrapani L, Licata A, Mazzola G, Soresi M. Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult. J Ultrasound. 2017;20:161-165. [PMID: 28593007 DOI: 10.1007/s40477-016-0227-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
286 Colaizzo D, Amitrano L, Iannaccone L, Vergura P, Cappucci F, Grandone E, Guardascione MA, Margaglione M. Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet 2007;44:412-6. [PMID: 17307838 DOI: 10.1136/jmg.2006.048371] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
287 Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007;13:2535-2540. [PMID: 17552000 DOI: 10.3748/wjq.v13.i18.2535] [Reference Citation Analysis]
288 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
289 Turnes J, García–pagán JC, González M, Aracil C, Calleja JL, Ripoll C, Abraldeṣ JG, Bañares R, Villanueva C, Albillos A, Ayuso JR, Gilabert R, Bosch J. Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation. Clinical Gastroenterology and Hepatology 2008;6:1412-7. [DOI: 10.1016/j.cgh.2008.07.031] [Cited by in Crossref: 113] [Cited by in F6Publishing: 73] [Article Influence: 8.7] [Reference Citation Analysis]
290 Manouchehri N, Kaneva P, Séguin C, Artho GP, Feldman LS. Screening for thrombophilia does not identify patients at risk of portal or splenic vein thrombosis following laparoscopic splenectomy. Surg Endosc 2016;30:2119-26. [PMID: 26307597 DOI: 10.1007/s00464-015-4476-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
291 Qi X, Wang J, Ren W, Bai M, Yang M, Han G, Fan D. Familial Budd-Chiari Syndrome in China: A Systematic Review of the Literature. ISRN Hepatol. 2013;2013:7. [PMID: 27335832 DOI: 10.1155/2013/763508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
292 El Sebay HM, Safan MA, Daoud AA, Tayel SI, A Nouh M, El Shafie S. Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients: Thrombophilia genes in Budd Chiari. Journal of Gastroenterology and Hepatology 2016;31:235-40. [DOI: 10.1111/jgh.13066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
293 Bayraktar Y, Harmanci O, Büyükasik Y, Shorbagi AI, Sungur AH, Boylu CA, Gürgey A, Balkanci F. JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci 2008;53:2778-83. [PMID: 18343999 DOI: 10.1007/s10620-008-0225-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
294 Garcia-Pagan JC, Valla DC. Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol. 2009;51:632-634. [PMID: 19660824 DOI: 10.1016/j.jhep.2009.06.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
295 Colaizzo D, Tiscia GL, Bafunno V, Amitrano L, Vergura P, Grandone E, Guardascione MA, Margaglione M. The JAK2 rs12343867 CC genotype frequently occurs in patients with splanchnic venous thrombosis without the JAK2V617F mutation: a retrospective study. Journal of Thrombosis and Haemostasis 2010;8:413-6. [DOI: 10.1111/j.1538-7836.2009.03691.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
296 Goel RM, Johnston EL, Patel KV, Wong T. Budd-Chiari syndrome: investigation, treatment and outcomes. Postgrad Med J 2015;91:692-7. [PMID: 26494427 DOI: 10.1136/postgradmedj-2015-133402] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
297 Keil R, Koželuhová J, Dolina J, Hep A, Kroupa R, Kojecký V, Krejčí T, Havlín J, Hadačová I, Segethová J, Koptová P, Zádorová Z, Matouš J, Frýbová B, Chmátal P, Wasserbauer M, Šťovíček J, Bae M, Guven T, Zaeem M, Hlava Š. Acute portal vein thrombosis in noncirrhotic patients – different prognoses based on presence of inflammatory markers: a long-term multicenter retrospective analysis. Scandinavian Journal of Gastroenterology 2019;54:1379-84. [DOI: 10.1080/00365521.2019.1677768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int. 2018;12:148-167. [PMID: 29464506 DOI: 10.1007/s12072-018-9844-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 8.7] [Reference Citation Analysis]
299 Heller MT, Tublin ME, Hosseinzadeh K, Fargiano A. Imaging of Hepatobiliary Disorders Complicating Pregnancy. American Journal of Roentgenology 2011;197:W528-36. [DOI: 10.2214/ajr.10.5128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
300 Chen S, Gao Y, Yu C, Zhang M, Nie Z. A Canine Model for IVC Occlusive Form of Budd–Chiari Syndrome Using Endovascular Technique. Cell Biochem Biophys 2013;67:1513-9. [DOI: 10.1007/s12013-013-9654-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
301 Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736-741. [PMID: 15094219 DOI: 10.1016/j.jhep.2004.01.001] [Cited by in Crossref: 362] [Cited by in F6Publishing: 264] [Article Influence: 21.3] [Reference Citation Analysis]
302 Qi X, Wu F, He C, Fan D, Han G. Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature. European Journal of Gastroenterology & Hepatology 2015;27:77-83. [DOI: 10.1097/meg.0000000000000221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
303 Tuite DJ, Rehman J, Davies MH, Patel JV, Nicholson AA, Kessel DO. Percutaneous Transsplenic Access in the Management of Bleeding Varices from Chronic Portal Vein Thrombosis. Journal of Vascular and Interventional Radiology 2007;18:1571-5. [DOI: 10.1016/j.jvir.2007.08.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
304 Spaander MCW, Van Buuren HR, Hansen BE, Janssen HLA. Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis: Ascites in patients with portal vein thrombosis. Alimentary Pharmacology & Therapeutics 2010;32:529-34. [DOI: 10.1111/j.1365-2036.2010.04375.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
305 Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50:195-203. [PMID: 19012988 DOI: 10.1016/j.jhep.2008.10.007] [Cited by in Crossref: 214] [Cited by in F6Publishing: 131] [Article Influence: 16.5] [Reference Citation Analysis]
306 Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg. 2005;241:208-216. [PMID: 15650628 DOI: 10.1097/01.sla.0000151794.28392.a6] [Cited by in Crossref: 190] [Cited by in F6Publishing: 143] [Article Influence: 11.9] [Reference Citation Analysis]
307 Madonna P, de Stefano V, Coppola A, Cerbone AM, di Minno G. G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology 2001;120:1059-60. [DOI: 10.1053/gast.2001.23083] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
308 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 46] [Article Influence: 13.7] [Reference Citation Analysis]
309 Chaudhuri M, Jayaranganath M, Chandra VS. Percutaneous Recanalization of an Occluded Hepatic Vein in a Difficult Subset of Pediatric Budd-Chiari Syndrome. Pediatr Cardiol 2012;33:806-10. [DOI: 10.1007/s00246-012-0188-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
310 Hammoud GM, Ibdah JA. The Liver in Pregnancy. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 919-40. [DOI: 10.1016/b978-1-4377-0881-3.00052-8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
311 Meloni MF, Andreano A, Lava M, Lazzaroni S, Okolicsanyi S, Sironi S. Segmental portal vein thrombosis after microwave ablation of liver tumors: Report of two cases. European Journal of Radiology Extra 2010;76:e95-8. [DOI: 10.1016/j.ejrex.2010.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
312 Terreni N, Vangeli M, Raimondo ML, Tibballs JM, Patch D, Burroughs AK. Late Intrahepatic Hematoma Complicating Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome. Cardiovasc Intervent Radiol 2007;30:335-8. [DOI: 10.1007/s00270-005-0229-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
313 Llop E, Seijo S. [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis]. Gastroenterol Hepatol 2016;39:403-10. [PMID: 26547613 DOI: 10.1016/j.gastrohep.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Ben Chaabane N, Melki W, Safer L, Bdioui F, Halara O, Saffar H. Ictère cholestatique secondaire à un cavernome porte : à propos d'un cas. Annales de Chirurgie 2006;131:543-6. [DOI: 10.1016/j.anchir.2006.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
315 Peynircioglu B, Shorbagi AI, Balli O, Cil B, Balkanci F, Bayraktar Y. Is there an alternative to TIPS? Ultrasound-guided direct intrahepatic portosystemic shunt placement in Budd-Chiari syndrome. Saudi J Gastroenterol. 2010;16:315-318. [PMID: 20871209 DOI: 10.4103/1319-3767.70633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
316 Inafuku H, Morishima Y, Nagano T, Arakaki K, Yamashiro S, Kuniyoshi Y. A three-decade experience of radical open endvenectomy with pericardial patch graft for correction of Budd-Chiari syndrome. J Vasc Surg. 2009;50:590-593. [PMID: 19700095 DOI: 10.1016/j.jvs.2009.03.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
317 Kathuria R, Srivastava A, Yachha SK, Poddar U, Baijal SS. Budd–Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome. European Journal of Gastroenterology & Hepatology 2014;26:1030-8. [DOI: 10.1097/meg.0000000000000144] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 4.1] [Reference Citation Analysis]
318 Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865-871. [PMID: 10845677 DOI: 10.1016/s0168-8278(00)80259-7] [Cited by in Crossref: 247] [Cited by in F6Publishing: 57] [Article Influence: 11.8] [Reference Citation Analysis]
319 Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007;13:2535-2540. [PMID: 17552000 DOI: 10.3748/wjg.v13.i18.2535] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
320 Bogin V, Marcos A, Shaw-Stiffel T. Budd-Chiari syndrome: in evolution. Eur J Gastroenterol Hepatol. 2005;17:33-35. [PMID: 15647637 DOI: 10.1097/00042737-200501000-00007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
321 Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterology 2002;97:535-41. [DOI: 10.1111/j.1572-0241.2002.05527.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 83] [Article Influence: 5.6] [Reference Citation Analysis]
322 Amitrano L, Ames PR, Guardascione MA, Lopez LR, Menchise A, Brancaccio V, Iannaccone L, Balzano A. Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis. Clin Appl Thromb Hemost. 2011;17:367-370. [PMID: 20530055 DOI: 10.1177/1076029610369797] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
323 Lefèvre A, Soyer P, Vahedi K, Guerrache Y, Bellucci S, Gault V, Boudiaf M. Multiple intra-abdominal venous thrombosis in ulcerative colitis: role of MDCT for detection. Clin Imaging 2011;35:68-72. [PMID: 21237420 DOI: 10.1016/j.clinimag.2010.03.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
324 Hernández-guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-pagán JC. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40:1197-202. [DOI: 10.1002/hep.20436] [Cited by in Crossref: 113] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
325 Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford). 2009;11:459-464. [PMID: 19816608 DOI: 10.1111/j.1477-2574.2009.00079.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
326 Kavanagh PM, Roberts J, Gibney R, Malone D, Hegarty J, Mccormick PA. Acute Budd-Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2004;19:1135-9. [DOI: 10.1111/j.1440-1746.2004.03427.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
327 Rodriguez-Luna H, Vargas HE. Portal vein thrombosis. Curr Treat Options Gastroenterol 2007;10:435-43. [PMID: 18221604 DOI: 10.1007/s11938-007-0043-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
328 Colaizzo D, Amitrano L, Tiscia GL, Scenna G, Grandone E, Guardascione MA, Brancaccio V, Margaglione M. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost. 2007;5:55-61. [PMID: 17059429 DOI: 10.1111/j.1538-7836.2006.02277.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 7.3] [Reference Citation Analysis]
329 Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd–Chiari syndrome. Nat Rev Gastroenterol Hepatol 2005;2:182-90. [DOI: 10.1038/ncpgasthep0143] [Cited by in Crossref: 59] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
330 Kanbay M, Karakus S, Yilmaz U. Portal Vein Thrombosis Due to Hyperhomocysteinemia Caused by Vitamin B-12 Deficiency. Dig Dis Sci 2005;50:2362-3. [DOI: 10.1007/s10620-005-3064-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
331 Hunninghake J, Murray BP, Ferraro D, Gancayco J. Acute intestinal ischaemia from a portal vein thrombosis in a young female smoker on an oral contraceptive. BMJ Case Rep 2018;2018:bcr-2018-225135. [PMID: 30077981 DOI: 10.1136/bcr-2018-225135] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
332 Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 2006;12:1273-7. [PMID: 16534884 DOI: 10.3748/wjg.v12.i8.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
333 Wolff M, Hirner A. Current state of portosystemic shunt surgery. Langenbecks Arch Surg 2003;388:141-9. [PMID: 12942328 DOI: 10.1007/s00423-003-0367-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
334 Kurtcehajic A, Zerem E, Hujdurovic A, Fejzic JA. Thrombotic risk factors in nonmalignant and noncirrhotic patients with portal vein thrombosis: need for extensive investigation. Eur J Gastroenterol Hepatol. 2016;28:116-118. [PMID: 26594916 DOI: 10.1097/MEG.0000000000000501] [Reference Citation Analysis]
335 Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman J, Urrunaga NH. Current and prospective therapies for acute liver failure. Disease-a-Month 2018;64:493-522. [DOI: 10.1016/j.disamonth.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]